To learn more about laboratory accreditation and the current environment for testing in Canada, Analytical Cannabis spoke with Andrew Adams, president and CEO of the Canadian Association for Laboratory Accreditation.
The trial will involve 90-day-long tests on rodents to assess how CBD affects the liver, if it promotes drowsiness, and how it may interact with other drugs.
In an upcoming virtual conference, the federal group will host a series of presentations on how sex and gender may affect an individual’s response to CBD and other cannabinoids.
DEA compliance experts Kelley Detweiler and Jack Teitelman share their tips on operating a cannabis company with care.
Major wildfires are threatening the lives and livelihoods of cannabis industry workers in California and Oregon, as both states continue to be scorched by the worst US wildfire season on record.
Speaking to Analytical Cannabis, the scientists behind the new method explain how it is able to determine whether the THC present in tested material is above or below one percent by weight, and thus whether it is either legal hemp or illicit cannabis.